2017 Change Readiness Index

No country is immune to change, and how a country prepares for and reacts to sudden shocks or long-term trends has a huge impact on the success and welfare of citizens and institutions.

The change readiness index provides an understanding of a country’s ability to withstand and capitalize on change, can help key stakeholders- including governments, policy makers, NGO’s, civil society institutions, development agencies, investors and private sector enterprises, strengthen a country’s readiness for change.

2017, Change Readiness Index, KPMG Global Thought Leadership

The real risk in life sciences

Over the past decade, compliance programs at life sciences companies have grown in scope and complexity. Now, executives and boards of directors are questioning whether these larger programs are effectively reducing their risks, or have they become too onerous to deliver real business value?

View full publication

Reimagine public transport bottlenecks

Pinch points in our public transport interchanges limit the network’s capacity. Our Associate Director of transport advisory suggests a way to relieve the pressure at these crucial bottlenecks, providing faster and more reliable journeys.

The capacities of major cities’ public transport systems are limited by particular bottlenecks, often at interchanges between modes of transport or tube lines. For example, staff at Victoria underground station in London often have to shut the station during busy periods when the flow of passengers arriving from the mainline station grows too great – leading to delays for passengers and creating risks as large crowds build up.

Some transport authorities have already recognised the potential of this approach: Transport for London, for example, publishes a metro map listing the time it takes to walk between stations. But such initiatives could have much more impact if people were provided with specific, targeted information that’s relevant to their journeys and incentivised to walk around particular bottlenecks at busy times.

To encourage people to walk around bottlenecks, transport authorities could provide rewards for taking the pressure off public transport.

View full publication

Value-based pricing in pharmaceuticals – hype or hope?

In the face of stagnant healthcare budgets, and ever-growing demand for care, pharmaceutical companies are under severe pressure to demonstrate the value of their products. Often it is no longer enough to show that drugs are efficacious; they now need to show improved outcomes that justify the price.

The industry is under the public and political microscope, with demands for an alternative to the traditional, sales-led approach to marketing. One payment model receiving increasing attention is value-based pricing (VBP).

Within a VBP arrangement, risk is shared between pharmaceutical companies and payers, which should focus all parties on appropriateness of use and on outcomes.

In this article, we outline the challenges facing VBP implementation, notably the need to define and measure outcomes, and overcome any regulatory and legal barriers. We discuss how to overcome these challenges, and feature a case study based on Novartis’ experience to date with the heart drug Entresto.

We believe that, with certain products, under certain conditions, VBP can add the value that healthcare systems and patients are looking for. This is the first in a series of discussions on VBP by KPMG professionals.

View full publication

On the runway

We are pleased to share with you a collection of case studies showcasing our capabilities in supporting the airline industry across the globe.

KPMG member firms have invested extensively in developing an experienced Global Aviation practise, with a deep understanding of the Aviation industry which we believe is both current and forward looking, thanks to KPMG’s knowledge, knowledge-sharing, industry training and use of professionals with direct experience in the industry.

KPMG’s presence in many international markets, combined with industry knowledge, positions us well to assist you in recognizing and making the most of opportunities, as well as implementing changes required by industry developments.

View full publication

Healthcare must climb the analytics maturity ladder

Most healthcare organizations are only halfway up the data and analytics maturity ladder. Heeding Affordable Care Act (ACA) mandates, they are instituting electronic health records (EHRs) and using analytics derived insights to improve short-term outcomes, such as decreased hospital admissions and complications.

Moving up the D&A maturity ladder in this new era of payment reform requires organizations to become data driven cultures and use data to gain a holistic picture of patients’ healthcare touch points.

View full publication

Assessing the true value of infrastructure investment

Infrastructure prioritization is rising up the agenda for governments, developers and investors around the world. Now, more than ever, governments and societies need a long-term plan that focuses on responding to the needs of society rather than the influences of the political cycle.

While the need for new appraisal and prioritization methodologies is critical, relatively limited research seems to have been conducted in this area. Few sources exist for those looking for leading practices and insights into developing their own assessment methodology. To close this gap and to help governments and project owners get more from their investments, we set out to research and assess current approaches to prioritization and assessment in a variety of markets around the world.

In this report, we shine the spotlight onto the emerging markets – South Africa, Brazil and India – as well as the UK which, arguably, boasts the most mature frameworks for assessing and prioritizing infrastructure investment.

View full publication

Foresight: A global infrastructure perspective

A combination of deregulation and technology is breaking down borders and could soon enable consumers to buy energy from a single provider – anywhere in the world. But will traditional energy companies or new players dominate this new market?

View full publication